Status:
COMPLETED
A Single and Multiple Ascending Dose Study to Evaluate the Safety, Pharmacokinetics, and Target Engagement of BMS-986147 in Healthy Subjects
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Healthy
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
This is the first clinical study with the BMS-986147 compound in healthy subjects. The purpose of this study is to guide the dose range and dose frequency for future studies with BMS-986147 and will p...
Eligibility Criteria
Inclusion
- For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
- Healthy men and women, ages 18 to 45 years
- Subjects must not have clinically significant deviation from normal: medical history, physical examination, ECGs and laboratory evaluations
- Women of child bearing potential are eligible for enrollment.
- Women must have a negative pregnancy test
Exclusion
- Evidence of organ dysfunction
- Any significant acute or chronic medical illness
- Inability to: tolerate oral medications, be venipunctured
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT02293629
Start Date
October 1 2014
End Date
November 1 2014
Last Update
May 19 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wcct Global, Llc
Cypress, California, United States, 90630